Hematopoietic stem cell transplants may prevent worsening of symptoms in multiple sclerosis

Written by Neuro Central

Hematopoietic stem cell transplants in people with multiple sclerosis (MS) may be able to reduce worsening of symptoms in the long-term, according to researchers based at the University of Genoa (Italy). Their study, which has been published in the journal Neurology, included 210 participants with MS who had received an autologous hematopoietic stem cell transplant between 1997 and 2019. Symptom severity for each participant was assessed at 6 months, 5 years and 10 years post-transplant. The team found that 80% of the individuals they had assessed after the first 5 years of study demonstrated no worsening of MS symptoms. After...

To view this content, please register now for access

It's completely free